Ovarian Neoplasm

Showing NaN - NaN of 4

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Ovarian Tumor Trial in United States (Dostarlimab, Bevacizumab, Niraparib)

Completed
  • Ovarian Neoplasm
  • Birmingham, Alabama
  • +9 more
Feb 20, 2023

Advanced Cancer, Ovarian Cancer, Breast Cancer Trial in United States (COM701, COM701 with Opdivo (Nivolumab).)

Recruiting
  • Advanced Cancer
  • +9 more
  • COM701
  • COM701 with Opdivo (Nivolumab).
  • Los Angeles, California
  • +10 more
Jan 25, 2022

Cancer in Women at Increased Genetic Risk of Ovarian Cancer

Completed
  • Breast Carcinoma
  • +3 more
  • Evaluation of Cancer Risk Factors
  • +3 more
  • Birmingham, Alabama
  • +140 more
Aug 31, 2020

Ovarian Tumor Trial in Worldwide (KU-0059436 (AZD2281)(PARP inhibitor))

Completed
  • Ovarian Neoplasm
  • KU-0059436 (AZD2281)(PARP inhibitor)
  • Los Angeles, California
  • +10 more
Jul 4, 2018